Furthermore, HNF4A loss in pancreatic cancer also drives metabolic reprogramming and correlates with a metabolic switch to dependence on glycolytic activity [52], suggesting a more widespread role for HNF4A in this context. This evidence concerns the gene HNF4A and familial pancreatic carcinoma.